Monoclonal anti-CGRP antibodies in post-menopausal women: a real-life study.

Guerzoni SimonaBaraldi CarloBrovia DariaCainazzo Maria MichelaLo Castro FlaviaPani Luca

Published in: Acta neurologica Belgica (2023)

The effectiveness of anti-CGRP monoclonal antibodies is almost the same between women in menopause and women of childbearing age, without appreciable differences between the different antibodies.

Keyphrases

polycystic ovary syndrome
pregnancy outcomes
randomized controlled trial
cervical cancer screening
systematic review
breast cancer risk
type diabetes
pregnant women
insulin resistance
postmenopausal women